Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial-Reference-Cited by-同舟云学术

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Published:2021-11 Issue:11 Volume:9 Page:1288-1298
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Rabe Klaus F,Celli Bartolome R,Wechsler Michael E,Abdulai Raolat M,Luo Xiaodong,Boomsma Maarten M,Staudinger Heribert,Horowitz Julie E,Baras Aris,Ferreira Manuel A,Ruddy Marcella K,Nivens Michael C,Amin Nikhil,Weinreich David M,Yancopoulos George D,Goulaouic Helene

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference32 articles.

1. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Soriano;Lancet Respir Med,2020

2. Update on clinical aspects of chronic obstructive pulmonary disease;Celli;N Engl J Med,2019

3. Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline;Wedzicha;Eur Respir J,2017

4. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline;Nici;Am J Respir Crit Care Med,2020

5. Health of former cigarette smokers aged 65 and over: United States, 2018;Kramarow;Natl Health Stat Rep,2020

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases;Frontiers in Immunology;2024-09-05

2. Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy;Journal for ImmunoTherapy of Cancer;2024-09

3. Mast cells contribute to T‐cell accumulation in the bronchoalveolar space in mice with IL‐33‐induced airway inflammation;Immunology;2024-08-12

4. Edwardsiella tarda induces airways inflammation and production of autoantibodies against lung tissues through regulation of the IL‐33‐ST2 axis;Immunology;2024-08-10

5. Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials;Clinical and Translational Science;2024-07-30